Literature DB >> 2458325

Immunochemical studies of epiretinal membranes using APAAP complexes: evidence for macrophage involvement in traumatic proliferative vitreoretinopathy.

M Weller1, K Heimann, P Wiedemann.   

Abstract

Proliferative vitreoretinopathy is characterized by cellular proliferations in the periretinal space resulting in traction retinal detachment. Numerous cellular elements and connective tissue components have been identified by morphologic criteria as well as immunochemical techniques. In this study, we used the recently introduced APAAP (alkaline phosphatase - anti-alkaline phosphatase) immunostaining procedure to identify macrophages, T-lymphocytes, the structural proteins fibronectin, vimentin, and cytokeratin, and a proliferating cell antigen, in eleven human epiretinal membranes obtained during vitreoretinal surgery. Our results confirm that the pathologic processes in PVR are not immunologically mediated, but reveal the features of physiologic wound healing and scar formation. Posttraumatic PVR seems to be characterized by a severe initial inflammatory reaction as evidenced by the presence of numerous macrophages, whereas idiopathic PVR, as a complication of retinal detachment, may be caused by different mechanisms in the early pathogenesis.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2458325     DOI: 10.1007/bf00130621

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  21 in total

1.  Cell-cell interaction and cell configuration related control of cytokeratins and vimentin expression in epithelial cells and in fibroblasts.

Authors:  A Ben-Ze'ev
Journal:  Ann N Y Acad Sci       Date:  1985       Impact factor: 5.691

Review 2.  Fibronectin.

Authors:  S K Akiyama; K M Yamada
Journal:  Adv Enzymol Relat Areas Mol Biol       Date:  1987

3.  The role of the macrophage in wound repair. A study with hydrocortisone and antimacrophage serum.

Authors:  S J Leibovich; R Ross
Journal:  Am J Pathol       Date:  1975-01       Impact factor: 4.307

4.  Epiretinal and vitreous membranes. Comparative study of 56 cases.

Authors:  A Kampik; K R Kenyon; R G Michels; W R Green; Z C de la Cruz
Journal:  Arch Ophthalmol       Date:  1981-08

5.  Vitreous aspirates from patients with proliferative vitreoretinopathy stimulate retinal pigment epithelial cell migration.

Authors:  P A Campochiaro; J A Jerdan; B M Glaser; A Cardin; R G Michels
Journal:  Arch Ophthalmol       Date:  1985-09

6.  [Proliferative vitreoretinopathy. Pathogenesis and possibilities for treatment with cytostatic drugs].

Authors:  P Wiedemann; K Heimann
Journal:  Klin Monbl Augenheilkd       Date:  1986-06       Impact factor: 0.700

7.  Postoperative retinal fibrosis--a controlled clinical study of systemic steroid therapy.

Authors:  F Koerner; A Merz; B Gloor; E Wagner
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1982       Impact factor: 3.117

8.  Light-microscopical analysis of focal adhesions of retinal pigmented epithelial cells.

Authors:  M Opas; V I Kalnins
Journal:  Invest Ophthalmol Vis Sci       Date:  1986-11       Impact factor: 4.799

9.  Intraocular daunorubicin for the treatment and prophylaxis of traumatic proliferative vitreoretinopathy.

Authors:  P Wiedemann; K Lemmen; R Schmiedl; K Heimann
Journal:  Am J Ophthalmol       Date:  1987-07-15       Impact factor: 5.258

10.  Fibronectin is produced by human macrophages.

Authors:  K Alitalo; T Hovi; A Vaheri
Journal:  J Exp Med       Date:  1980-03-01       Impact factor: 14.307

View more
  12 in total

1.  Immunoglobulin G, complement factor C3 and lymphocytes in proliferative intraocular disorders.

Authors:  M Weller; R Clausen; M Bresgen; K Heimann; P Wiedemann
Journal:  Int Ophthalmol       Date:  1990-07       Impact factor: 2.031

2.  MCP-1-activated monocytes induce apoptosis in human retinal pigment epithelium.

Authors:  Dongli Yang; Susan G Elner; Xun Chen; Matthew G Field; Howard R Petty; Victor M Elner
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-07-29       Impact factor: 4.799

3.  Macrophages in the pathobiology of epiretinal membranes: multifunctional cells for a multistage process.

Authors:  P Hiscott
Journal:  Br J Ophthalmol       Date:  1993-11       Impact factor: 4.638

4.  HLA antigens and lymphocytes in proliferative vitreoretinopathy.

Authors:  R Proença; M Carvalho; D Proença; J Verissimo; I Regadas; A Travassos
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1994-01       Impact factor: 3.117

5.  Transferrin and transferrin receptor expression in intraocular proliferative disease. APAAP-immunolabeling of retinal membranes and ELISA for vitreal transferrin.

Authors:  M Weller; P Wiedemann; H Moter; K Heimann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1989       Impact factor: 3.117

Review 6.  Proliferative vitreoretinopathy--is it anything more than wound healing at the wrong place?

Authors:  M Weller; P Wiedemann; K Heimann
Journal:  Int Ophthalmol       Date:  1990-03       Impact factor: 2.031

7.  Vitronectin and proliferative intraocular disorders. II. Expression of cell surface receptors for fibronectin and vitronectin in periretinal membranes.

Authors:  M Weller; P Wiedemann; M Bresgen; K Heimann
Journal:  Int Ophthalmol       Date:  1991-03       Impact factor: 2.031

8.  Origin of fibronectin in epiretinal membranes of proliferative vitreoretinopathy and proliferative diabetic retinopathy.

Authors:  S Grisanti; K Heimann; P Wiedemann
Journal:  Br J Ophthalmol       Date:  1993-04       Impact factor: 4.638

9.  Macrophages in proliferative vitreoretinopathy and proliferative diabetic retinopathy: differentiation of subpopulations.

Authors:  P Esser; K Heimann; P Wiedemann
Journal:  Br J Ophthalmol       Date:  1993-11       Impact factor: 4.638

10.  Differential cytokine expression of human retinal pigment epithelial cells in response to stimulation by C5a.

Authors:  Y Fukuoka; M Strainic; M E Medof
Journal:  Clin Exp Immunol       Date:  2003-02       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.